Trial NCT03488225

View at ClinicalTrials.gov 
Org. Study IDs: 2015-0922
Secondary IDs: 2015-0922 NCI-2018-00760 P30CA016672

Last trial update was posted on 2024-02-09

MeSH Interventions

Antibodies Antibodies, Monoclonal Antineoplastic Agents, Immunological BB 1101 Calcium Calcium, Dietary Cortisone Cyclophosphamide Cytarabine Dexamethasone Dexamethasone acetate Doxorubicin Folic Acid Immunoglobulins Inotuzumab Ozogamicin Leucovorin Levoleucovorin Liposomal doxorubicin Mercaptopurine Methotrexate Ofatumumab Prednisone Rituximab Vincristine

MeSH Conditions

Leukemia Leukemia, Lymphoid Philadelphia Chromosome Precursor Cell Lymphoblastic Leukemia-Lymphoma

Other Conditions

Acute Lymphoblastic Leukemia in Remission B Acute Lymphoblastic Leukemia B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative

Stopping Reasons

the study was closed early due to competing trials

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID